Siamab Therapeutics (formerly Sialix, Inc.) is a biopharmaceutical company developing novel cancer immunotherapies. Siamab has developed a platform of technologies that enable the rapid discovery and development of therapeutic antibodies that bind to a novel class of carbohydrate antigens present on cancer cells. Based in Newton, MA, the company’s lead program is in preclinical studies for the treatment of solid tumors.
View Top Employees from Siamab Therapeutics, Inc.| Website | https://www.siamab.com |
| Revenue | $1 million |
| Funding | $7.5 million |
| Employees | 7 (0 on RocketReach) |
| Founded | 2006 |
| Address | 90 Bridge St, Ste 100, Newton, Massachusetts 02458, US |
| Phone | (857) 222-5817 |
| Fax | (617) 752-3653 |
| Technologies |
G Suite,
Gmail,
Wix
+1 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Biopharma, Glycobiology, Cancer, Healthcare, Health Care, Sialic Acids, Science and Engineering, Oncology, Therapeutics, TACAs |
| Web Rank | 18 Million |
| Competitors | AgilVax, Altor Bioscience Corporation, Kronos Bio, Soricimed Biopharma Inc., iTeos Therapeutics |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular Siamab Therapeutics, Inc. employee's phone or email?
Siamab Therapeutics, Inc. Questions
The Siamab Therapeutics, Inc. annual revenue was $1 million in 2024.
Siamab Therapeutics, Inc. is based in Newton, Massachusetts.
The NAICS codes for Siamab Therapeutics, Inc. are [54, 541, 541714, 54171, 5417].
The SIC codes for Siamab Therapeutics, Inc. are [87, 873].
Related Companies
